A Murine Model of Dermatophytosis

Sunna Nabeela1, Neha Agrawal2, Priya Uppuluri1,3

  • 1Institute for Infection and Immunity, Lundquist Institute for Biomedical Innovation at Harbor-University of California Los Angeles Medical Center, Torrance, California.

Current Protocols
|January 14, 2026
PubMed

Insights

A new diabetic mouse model accurately mimics human dermatophytosis, aiding the study of fungal skin infections and antifungal drug development for recalcitrant cases.

Area of Science:

  • Mycology
  • Infectious Diseases
  • Animal Models

Background:

  • Dermatophytes cause superficial fungal infections.
  • Recalcitrant infections by Trichophyton mentagrophytes complex and T. indotineae are increasing, especially in diabetic patients.
  • There is a need for reliable small-animal models to study these infections and test treatments.

Purpose of the Study:

  • To develop and validate a diabetic mouse model for dermatophytosis.
  • To provide a reproducible platform for studying fungal pathogenesis and evaluating antifungal therapies.
  • To address the challenge of emerging resistant fungal species.

Main Methods:

  • Preparation of dermatophyte conidial inocula.
  • Pharmacological induction of diabetes or immunosuppression in mice.
  • Standardized infection of abraded dorsal skin.
  • Assessment of fungal burden and pathology (clinical scoring, CFU counts, histopathology).

Main Results:

  • The model faithfully mimics human dermatophytosis.
  • The protocol ensures reproducibility through critical parameter guidance.
  • The model has been successfully used to evaluate antifungal drugs.

Conclusions:

  • This diabetic mouse model offers a clinically relevant and cost-effective platform for dermatophyte research.
  • The model is adaptable for studying emerging resistant species like T. indotineae.
  • It facilitates the development of new antifungal strategies.